voacamine has been researched along with Bone Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altieri, B; Condello, M; Galantini, L; Giansanti, L; Mancini, G; Meschini, S | 1 |
| Arancia, G; Condello, M; Corinti, S; Cosentino, D; Di Felice, G; Gallo, FR; Meschini, S; Multari, G | 1 |
| Arancia, G; Condello, M; Gallo, FR; Meschini, S; Multari, G | 1 |
3 other study(ies) available for voacamine and Bone Cancer
| Article | Year |
|---|---|
Influence of lipid composition on the ability of liposome loaded voacamine to improve the reversion of doxorubicin resistant osteosarcoma cells.
Topics: Antibiotics, Antineoplastic; Bone Neoplasms; Cell Proliferation; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Ibogaine; Lipids; Liposomes; Molecular Conformation; Osteosarcoma; Particle Size; Surface Properties; Tumor Cells, Cultured | 2019 |
Voacamine modulates the sensitivity to doxorubicin of resistant osteosarcoma and melanoma cells and does not induce toxicity in normal fibroblasts.
Topics: Alkaloids; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Bone Neoplasms; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fibroblasts; Fluorescent Antibody Technique; Humans; Ibogaine; Melanoma; Molecular Structure; Osteosarcoma | 2014 |
High-performance thin-layer chromatography for the evaluation of voacamine intracellular concentration related to its cytotoxic effect.
Topics: Antineoplastic Agents; Apoptosis; Biological Transport; Bone Neoplasms; Cell Line, Tumor; Cell Shape; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Ibogaine; Osteosarcoma; Reproducibility of Results | 2015 |